The Effect of Reduced Dose of Enoxaparin on the Outcomes of Treatment With Enoxaparin

Hadassah Medical Center

Status: Unknown

Conditions: Venous Thromboembolism; Atrial Fibrillation; Acute Coronary Syndrome; Hypercoagulability

Study type: Observational

Funder types: Other

Identifiers

NCT00354796

enoxap-HMO-CTIL

Details and patient eligibility

About

We hypothesize that reduced dose of enoxaparin in elderly patients will result in reduced proportion of patients with therapeutic anti Xa activity and reduced clinical efficacy.

Full description

Patients treated with enoxaparin will be followed, sociodemographic , clinical and laboratory data will be collected. Clinical efficacy as well as adverse events will be monitored.

Enrollment: 500 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• treatment with enoxaparin

Exclusion criteria

• no